Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning

Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning

<p><strong>Objective:</strong> Complex phenotypes captured on histological slides represent the biological processes at play in individual cancers but the link to underlying molecular classification has not been clarified or systematised. In colorectal cancer (CRC), histological gr...

Bibliografske podrobnosti
Main Authors:	Sirinukunwattana, K, Domingo-Villanueva, E, Richman, S, Blake, A, Verrill, C, Leedham, SJ, Wu, C-H, Maughan, T, Rittscher, J, Koelzer, VH
Format:	Journal article
Jezik:	English
Izdano:	BMJ Publishing Group 2020

Podobne knjige/članki

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
od: Lafarge, MW, et al.
Izdano: (2024)

Towards the identification of histology based subtypes in prostate cancer
od: Chatrian, A, et al.
Izdano: (2019)

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
od: Maxime W. Lafarge, et al.
Izdano: (2024-04-01)

Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision
od: Rebersek Martina
Izdano: (2020-05-01)

Enhancing local context of histology features in vision transformers
od: Wood, R, et al.
Izdano: (2022)

Precision immunoprofiling by image analysis and artificial intelligence
od: Koelzer, V, et al.
Izdano: (2018)

Improving whole slide segmentation through visual context: a systematic study
od: Sirinukunwattana, K, et al.
Izdano: (2018)

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer
od: Malla, SB, et al.
Izdano: (2024)

Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype
od: Jiayin Deng, et al.
Izdano: (2021-10-01)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
od: Peter W. Eide, et al.
Izdano: (2021-07-01)

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
od: Niek A. Peters, et al.
Izdano: (2022-09-01)

A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer
od: Min-Er Zhong, et al.
Izdano: (2022-06-01)

Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics
od: Alberto Valdeolivas, et al.
Izdano: (2024-01-01)

Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer
od: Yujie Lu, et al.
Izdano: (2023-06-01)

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
od: Jitske van den Bulk, et al.
Izdano: (2019-12-01)

Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies
od: Alderdice, M, et al.
Izdano: (2018)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
od: Anita Sveen, et al.
Izdano: (2017-05-01)

Seed and Soil: Consensus Molecular Subgroups (CMS) and Tumor Microenvironment Features Between Primary Lesions and Metastases of Different Organ Sites in Colorectal Cancer
od: Luo Q, et al.
Izdano: (2024-03-01)

TP53 mutation status and consensus molecular subtypes of colorectal cancer in patients from Rwanda
od: Augustin Nzitakera, et al.
Izdano: (2024-10-01)

Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer
od: Anna Jakab, et al.
Izdano: (2024-04-01)

Identifying essential genes in genome-scale metabolic models of consensus molecular subtypes of colorectal cancer.
od: Chao-Ting Cheng, et al.
Izdano: (2023-01-01)

Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer
od: Jonas Langerud, et al.
Izdano: (2024-05-01)

A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy
od: Liam F. Spurr, et al.
Izdano: (2022-10-01)

A graph based neural network approach to immune profiling of multiplexed tissue samples
od: Martin, NG, et al.
Izdano: (2022)

Ink removal from histopathology whole slide images by combining classification, detection and image generation models
od: Ali, S, et al.
Izdano: (2019)

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer
od: Inge van denBerg, et al.
Izdano: (2021-12-01)

Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies
od: Chatrian, A, et al.
Izdano: (2021)

Automating the CMS DAQ
od: Bauer, Gerry P, et al.
Izdano: (2019)

The potential of artificial intelligence to detect lymphovascular invasion in testicular cancer
od: Ghosh, A, et al.
Izdano: (2021)

Automated quality assessment of large digitised histology cohorts by artificial intelligence
od: Haghighat, M, et al.
Izdano: (2022)

Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival
od: Barnabas Irmer, et al.
Izdano: (2025-03-01)

Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends
od: Manas Sehgal, et al.
Izdano: (2024-02-01)

Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
od: Irshad, S, et al.
Izdano: (2017)

Bone Morphogenetic Protein and Notch signaling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer
od: Irshad, S, et al.
Izdano: (2017)

Comparative analysis of mitochondrial genomes of maize CMS-S subtypes provides new insights into male sterility stability
od: Senlin Xiao, et al.
Izdano: (2022-10-01)

The CMS electronic logbook
od: Ma, Fermi P., et al.
Izdano: (2013)

The CMS Collaboration
od: Abbaneo, D, et al.
Izdano: (2009)

Exotica in CMS
od: Wulz Claudia-Elisabeth
Izdano: (2016-01-01)

The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer.
od: McCuaig, S, et al.
Izdano: (2020)

Molecular subtypes of leiomyosarcoma: Moving toward a consensus
od: Jessica Burns, et al.
Izdano: (2022-12-01)